Last Posted: May 04, 2019
- What is in a Name? Parent, Professional and Policy-Maker Conceptions of Consent-Related Language in the Context of Newborn Screening
SG Nicholls et al, Public Health Ethics, May 4, 2019 - A Nationwide Retrospective Observational Study Of Population Newborn Screening For Medium-Chain Acyl-CoA Dehydrogenase (MCAD) Deficiency In The Netherlands.
Jager Emmalie A et al. Journal of inherited metabolic disease 2019 Apr - ACOG Committee Opinion No. 778 Summary: Newborn Screening and the Role of the Obstetrician-Gynecologist.
et al. Obstetrics and gynecology 2019 May 133(5) 1073-1074 - ACOG Committee Opinion No. 778: Newborn Screening and the Role of the Obstetrician-Gynecologist.
et al. Obstetrics and gynecology 2019 May 133(5) e357-e361 - Clinical and biochemical outcome of patients with very long-chain acyl-CoA dehydrogenase deficiency.
Rovelli Valentina et al. Molecular genetics and metabolism 2019 Apr - Cost-effectiveness of newborn screening for severe combined immunodeficiency.
Van der Ploeg Catharina P B et al. European journal of pediatrics 2019 May 178(5) 721-729 - High frequency of non-classical congenital adrenal hyperplasia form among children with persistently elevated levels of 17-hydroxyprogesterone after newborn screening.
Castro Patrícia S et al. Journal of pediatric endocrinology & metabolism : JPEM 2019 Apr - Newborn screening for SMA in Southern Belgium.
Boemer François et al. Neuromuscular disorders : NMD 2019 Feb - Optimization and application of a dried blood spot-based genetic screening method for thalassemia in Shenzhen newborns.
Wen Wei et al. World journal of pediatrics : WJP 2019 Apr - Applying a multiplexed primer extension method on dried blood spots increased the detection of carriers at risk of glucose-6-phosphate dehydrogenase deficiency in newborn screening program.
Chiu Yen-Hui et al. Clinica chimica acta; international journal of clinical chemistry 2019 Apr
No hay comentarios:
Publicar un comentario